
|Articles|June 1, 2004
Biotech company previews cutting edge dermatologic research
San Francisco - When Ivor Caro, M.D., now medical director of dermatology at Genentech Inc., joined the South San Francisco-based biotechnology company last year, he saw great potential for dermatology research.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
3
Experts See Promise in AI for Atopic Dermatitis Care
4
New Analysis Finds Radiofrequency Microneedling Superior for Rosacea Erythema and Patient Satisfaction
5


















